Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Adrenalone
2. Stryphnasal
1. 62-13-5
2. Adrenalone Hcl
3. Adrenone Hydrochloride
4. Kephrine Hydrochloride
5. 3',4'-dihydroxy-2-(methylamino)acetophenone Hydrochloride
6. Epinephrine Ketone Hydrochloride
7. Adrenalone (hydrochloride)
8. 1-(3,4-dihydroxyphenyl)-2-(methylamino)ethanone Hydrochloride
9. Nn82ywe2ic
10. 1-(3,4-dihydroxyphenyl)-2-(methylamino)ethan-1-one Hydrochloride
11. Ethanone, 1-(3,4-dihydroxyphenyl)-2-(methylamino)-, Hydrochloride
12. Adrenalone, Hydrochloride
13. Stryphnonasal
14. 1-(3,4-dihydroxy-phenyl)-2-methylamino-ethanone Hydrochloride
15. Nsc-9407
16. 1-(3,4-dihydroxyphenyl)-2-(methylamino)ethanone;hydrochloride
17. Adrenalonium Chloratum
18. Stryphnasal
19. Adrenone Hcl
20. 1-(3,4-dihydroxyphenyl)-2-(methylamino)ethanone Hydrochloride (adrenalone Hydrochloride)
21. Nsc 9407
22. Einecs 200-525-7
23. Unii-nn82ywe2ic
24. Adrenolone Hydrochloride
25. Stryphnasal (tn)
26. Adrenalonehydrochloride
27. Alpha-methylamino-3',4'-dihydroxyacetophenone Hydrochloride
28. Schembl6662605
29. Dtxsid30211026
30. Nsc9407
31. Wln: Qr Bq Dv1m1 &gh
32. (2-(3,4-dihydroxyphenyl)-2-oxoethyl)methylammonium Chloride
33. 1-(3,4-dihydroxyphenyl)-2-(methylamino)ethanone,hydrochloride
34. Pharmakon1600-01506124
35. Acetophenone, 3',4'-dihydroxy-2-(methylamino)-, Hydrochloride
36. Hy-b1308
37. Adrenalone Hydrochloride [mi]
38. Nsc760356
39. S3185
40. Akos007930211
41. Ccg-213617
42. Cs-4906
43. Nsc-760356
44. Sb37953
45. Adrenalone Hydrochloride [mart.]
46. Adrenalone Hydrochloride [usp-rs]
47. Adrenalone Hydrochloride [who-dd]
48. Ac-32691
49. As-71891
50. Db-054071
51. A1234
52. Ft-0621929
53. Sw220261-1
54. D07560
55. D88399
56. A833601
57. W-105045
58. Q27284967
59. 3',4'-dihydroxy-2-methylaminoacetophenone Hydrochloride
60. Acetophenone,4'-dihydroxy-2-(methylamino)-, Hydrochloride
61. Ethanone,4-dihydroxyphenyl)-2-(methylamino)-, Hydrochloride
62. .alpha.-methylamino-3',4'-dihydroxyacetophenone Hydrochloride
63. 1-(3,4-dihydroxyphenyl)-2-(methylamino)-ethanone Hydrochloride
64. 1-(3,4-dihydroxyphenyl)-2-(methylamino)-ethanonhydrochloride
65. 3'4'-dihydroxy-2-(methylamino)acetophenone Hydrochloride
66. Ethanone, 1-(3,4-dihydroxyphenyl)-2-(methylamino)-, Hydrochloride (1:1)
67. Adrenalone Hydrochloride, United States Pharmacopeia (usp) Reference Standard
68. 3',4'-dihydroxy-2-(methylamino)acetophenone Hydrochloride, >=98.0% (calc. Based On Dry Substance, At)
Molecular Weight | 217.65 g/mol |
---|---|
Molecular Formula | C9H12ClNO3 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 217.0505709 g/mol |
Monoisotopic Mass | 217.0505709 g/mol |
Topological Polar Surface Area | 69.6 Ų |
Heavy Atom Count | 14 |
Formal Charge | 0 |
Complexity | 184 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Vasoconstrictor Agents
Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)
Hemostatics
Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. (See all compounds classified as Hemostatics.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
73
PharmaCompass offers a list of Adrenalone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Adrenalone manufacturer or Adrenalone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Adrenalone manufacturer or Adrenalone supplier.
PharmaCompass also assists you with knowing the Adrenalone API Price utilized in the formulation of products. Adrenalone API Price is not always fixed or binding as the Adrenalone Price is obtained through a variety of data sources. The Adrenalone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 02270_FLUKA manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 02270_FLUKA, including repackagers and relabelers. The FDA regulates 02270_FLUKA manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 02270_FLUKA API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 02270_FLUKA supplier is an individual or a company that provides 02270_FLUKA active pharmaceutical ingredient (API) or 02270_FLUKA finished formulations upon request. The 02270_FLUKA suppliers may include 02270_FLUKA API manufacturers, exporters, distributors and traders.
click here to find a list of 02270_FLUKA suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 02270_FLUKA DMF (Drug Master File) is a document detailing the whole manufacturing process of 02270_FLUKA active pharmaceutical ingredient (API) in detail. Different forms of 02270_FLUKA DMFs exist exist since differing nations have different regulations, such as 02270_FLUKA USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 02270_FLUKA DMF submitted to regulatory agencies in the US is known as a USDMF. 02270_FLUKA USDMF includes data on 02270_FLUKA's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 02270_FLUKA USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 02270_FLUKA suppliers with USDMF on PharmaCompass.
02270_FLUKA Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 02270_FLUKA GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 02270_FLUKA GMP manufacturer or 02270_FLUKA GMP API supplier for your needs.
A 02270_FLUKA CoA (Certificate of Analysis) is a formal document that attests to 02270_FLUKA's compliance with 02270_FLUKA specifications and serves as a tool for batch-level quality control.
02270_FLUKA CoA mostly includes findings from lab analyses of a specific batch. For each 02270_FLUKA CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
02270_FLUKA may be tested according to a variety of international standards, such as European Pharmacopoeia (02270_FLUKA EP), 02270_FLUKA JP (Japanese Pharmacopeia) and the US Pharmacopoeia (02270_FLUKA USP).